These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8781780)

  • 21. Baralyme dehydration increases and soda lime dehydration decreases the concentration of compound A resulting from sevoflurane degradation in a standard anesthetic circuit.
    Eger EI; Ionescu P; Laster MJ; Weiskopf RB
    Anesth Analg; 1997 Oct; 85(4):892-8. PubMed ID: 9322476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation of sevoflurane in dogs and rats.
    Martis L; Lynch S; Napoli MD; Woods EF
    Anesth Analg; 1981 Apr; 60(4):186-91. PubMed ID: 6782910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparison.
    Kharasch ED; Jubert C
    Anesthesiology; 1999 Nov; 91(5):1267-78. PubMed ID: 10551576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sevoflurane degradation by carbon dioxide absorbents may produce more than one nephrotoxic compound in rats.
    Stabernack CR; Eger EI; Warnken UH; Förster H; Hanks DK; Ferrell LD
    Can J Anaesth; 2003 Mar; 50(3):249-52. PubMed ID: 12620947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1.
    Garton KJ; Yuen P; Meinwald J; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1995 Dec; 23(12):1426-30. PubMed ID: 8689955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism by rat hepatic microsomes of fluorinated ether anesthetics following isoniazid administration.
    Rice SA; Sbordone L; Mazze RI
    Anesthesiology; 1980 Dec; 53(6):489-93. PubMed ID: 7457965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal safety and extrahepatic defluorination of sevoflurane in hepatic transplantations.
    Kanbak M; Karagoz AH; Erdem N; Oc B; Saricaoglu F; Ertas N; Berkkan A; Abbasoglu O; Aypar U
    Transplant Proc; 2007 Jun; 39(5):1544-8. PubMed ID: 17580185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism and toxicity of the new anesthetic agents.
    Kharasch ED
    Acta Anaesthesiol Belg; 1996; 47(1):7-14. PubMed ID: 8651050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiorespiratory effects of low-flow and closed circuit inhalation anesthesia, using sevoflurane delivered with an in-circuit vaporizer and concentrations of compound A.
    Muir WW; Gadawski J
    Am J Vet Res; 1998 May; 59(5):603-8. PubMed ID: 9582964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sevoflurane: metabolism and toxicity].
    Nuscheler M; Conzen P; Peter K
    Anaesthesist; 1998 Nov; 47 Suppl 1():S24-32. PubMed ID: 9893877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of sevoflurane on the metabolism and renal effects of compound A in rats.
    Kharasch ED; Schroeder JL; Sheffels P; Liggitt HD
    Anesthesiology; 2005 Dec; 103(6):1183-8. PubMed ID: 16306730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cysteine conjugate beta-lyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A.
    Iyer RA; Frink EJ; Ebert TJ; Anders MW
    Anesthesiology; 1998 Mar; 88(3):611-8. PubMed ID: 9523802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A).
    Iyer RA; Anders MW
    Chem Res Toxicol; 1997 Jul; 10(7):811-9. PubMed ID: 9250416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species.
    Goasduff T; Cederbaum AI
    Arch Biochem Biophys; 1999 Oct; 370(2):258-70. PubMed ID: 10510285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers.
    Ebert TJ; Messana LD; Uhrich TD; Staacke TS
    Anesth Analg; 1998 Mar; 86(3):662-7. PubMed ID: 9495434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Compound A: toxicology and clinical relevance].
    Kharasch ED
    Anaesthesist; 1998 Nov; 47 Suppl 1():S7-10. PubMed ID: 9893874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compound A and carbon monoxide production from sevoflurane and seven different types of carbon dioxide absorbent in a patient model.
    Keijzer C; Perez RS; de Lange JJ
    Acta Anaesthesiol Scand; 2007 Jan; 51(1):31-7. PubMed ID: 17096668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The compound A concentration in a low-flow anesthesia circuit using the new CO2 absorbent SPHERASORB].
    Obata R; Bito H; Katoh T; Sato S
    Masui; 2000 May; 49(5):504-8. PubMed ID: 10846381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.